Medical devices• Updated Jan 3• Tecentriq
TECENTRIQ recall in Canada: Risk of immune-related myositis
This recall involves TECENTRIQ (atezolizumab) concentrate for solution for infusion, 60 mg / mL in 20 mL single use vial...
Tecentriq Recalls in Canada
All product recalls associated with Tecentriq in Canada, sourced from Health Canada, Transport Canada, and the CFIA.
3 recalls
Most recent: Mar 13, 2019
Health products• Updated Jan 3• Tecentriq
TECENTRIQ recall in Canada: risk of immune-related nephritis
This recall involves TECENTRIQ (atezolizumab) concentrate for solution for infusion, 60 mg / mL in 20 mL single-use vial...
Health products• Updated Jan 3• Tecentriq
TECENTRIQ (atezolizumab) recall in Canada: risk of myocarditis
This recall involves TECENTRIQ (atezolizumab) concentrate for solution for infusion, 60 mg / mL in 20 mL single use vial...